ΔNp63 induces β-catenin nuclear accumulation and signaling

被引:177
作者
Patturajan, M
Nomoto, S
Sommer, M
Fomenkov, A
Hibi, K
Zangen, R
Poliak, N
Califano, J
Trink, B
Ratovitski, E [1 ]
Sidransky, D
机构
[1] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA
关键词
D O I
10.1016/S1535-6108(02)00057-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The P53 homolog p63 encodes multiple proteins with transactivating, apoptosis-inducing, and oncogenic activities. We showed that p63 is amplified and that DeltaNp63 isotypes are overexpressed in squamous cell carcinoma (SCC) and enhance oncogenic growth in vitro and in vivo. Moreover, p53 associated with DeltaNp63cx and mediated its degradation. Here, we report that DeltaNp63 associates with the B56alpha regulatory subunit of protein phosphatase 2A (PP2A) and glycogen synthase kinase 3beta (GSK3beta), leading to a dramatic inhibition of PP2A-mediated GSK3beta reactivation. The inhibitory effect of DeltaNp63 on GSK3beta mediates a decrease in phosphorylation levels of beta-catenin, which induces intranuclear accumulation of beta-catenin and activates beta-catenin-dependent transcription. Our results suggest that DeltaNp63 isotypes act as positive regulators of the beta-catenin signaling pathway, providing a basis for their oncogenic properties.
引用
收藏
页码:369 / 379
页数:11
相关论文
共 47 条
[1]   Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts [J].
Bafico, A ;
Gazit, A ;
Wu-Morgan, SS ;
Yaniv, A ;
Aaronson, SA .
ONCOGENE, 1998, 16 (21) :2819-2825
[2]  
Barker N, 2000, BIOESSAYS, V22, P961
[3]  
BRADLEY RS, 1995, MOL CELL BIOL, V15, P4616
[4]   A common human skin tumour is caused by activating mutations in β-catenin [J].
Chan, EF ;
Gat, U ;
McNiff, JM ;
Fuchs, E .
NATURE GENETICS, 1999, 21 (04) :410-413
[5]   High level expression of ΔN-p63:: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? [J].
Crook, T ;
Nicholls, JM ;
Brooks, L ;
O'Nions, J ;
Allday, MJ .
ONCOGENE, 2000, 19 (30) :3439-3444
[6]  
Dahmen RP, 2001, CANCER RES, V61, P7039
[7]  
de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847
[8]   GSK3 takes centre stage more than 20 years after its discovery [J].
Frame, S ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2001, 359 (01) :1-16
[9]   Identification of c-MYC as a target of the APC pathway [J].
He, TC ;
Sparks, AB ;
Rago, C ;
Hermeking, H ;
Zawel, L ;
da Costa, LT ;
Morin, PJ ;
Vogelstein, B ;
Kinzler, KW .
SCIENCE, 1998, 281 (5382) :1509-1512
[10]   AIS is an oncogene amplified in squamous cell carcinoma [J].
Hibi, K ;
Trink, B ;
Patturajan, M ;
Westra, WH ;
Caballero, OL ;
Hill, DE ;
Ratovitski, EA ;
Jen, J ;
Sidransky, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5462-5467